Lists of disasters

Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, August 9, 2022 - 8:00am

LONDON and RALEIGH, N.C., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the three months ended June 30, 2022, and provides a corporate update.

Key Points: 
  • Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs.
  • Ensifentrine met the primary endpoint in ENHANCE-2 demonstrating a statistically significant and clinically meaningful improvement in lung function.
  • Verona Pharma continues to monitor the impact of the COVID-19 pandemic on its operations and clinical trials, in particular the timelines and costs of its Phase 3 clinical program ENHANCE.
  • Verona Pharma is conducting ENHANCE-1 at a number of clinical trial sites in Russia and Europe (but not including Ukraine).

Verona Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-2 Trial for COPD

Retrieved on: 
Tuesday, August 9, 2022 - 7:00am

LONDON and RALEIGH, N.C., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), today announces its top-line Phase 3 ENHANCE-2 (“Ensifentrine as a Novel inHAled Nebulized COPD thErapy”) trial results evaluating nebulized ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease (“COPD”). The ENHANCE-2 trial has successfully met its primary endpoint, as well as secondary endpoints demonstrating improvements in lung function, and significantly reduced the rate and risk of COPD exacerbations.

Key Points: 
  • The Company is evaluating nebulized ensifentrine in its Phase 3 clinical program ENHANCE (Ensifentrine as a Novel inHAled Nebulized COPD thErapy) for COPD maintenance treatment.
  • Ensifentrine met the primary endpoint in ENHANCE-2 demonstrating a statistically significant and clinically meaningful improvement in lung function.
  • In addition, ensifentrine significantly reduced the rate of COPD exacerbations in the ENHANCE-2 trial.
  • Verona Pharma is conducting ENHANCE-1 at a number of clinical trial sites in Russia and Europe (but not including Ukraine).

PennantPark Floating Rate Capital Ltd. Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Tuesday, August 9, 2022 - 2:52am

In addition, in connection with this offering, the Company has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock.

Key Points: 
  • In addition, in connection with this offering, the Company has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock.
  • About PennantPark Floating Rate Capital Ltd.
    PennantPark Floating Rate Capital Ltd. is a business development company which primarily invests in U.S. middle-market companies in the form of floating rate senior secured loans, including first lien secured debt, second lien secured debt and subordinated debt.
  • PennantPark Floating Rate Capital Ltd. is managed by PennantPark Investment Advisers, LLC.
  • PennantPark Floating Rate Capital Ltd. undertakes no duty to update any forward-looking statement made herein.

Horizon Global Announces Review of Strategic Alternatives

Retrieved on: 
Monday, August 8, 2022 - 10:45pm

Horizon Global Corporation (NYSE: HZN), one of the worlds leading manufacturers of branded towing and trailering equipment, today announced that the Companys Board of Directors has authorized the review of strategic alternatives to enhance shareholder value.

Key Points: 
  • Horizon Global Corporation (NYSE: HZN), one of the worlds leading manufacturers of branded towing and trailering equipment, today announced that the Companys Board of Directors has authorized the review of strategic alternatives to enhance shareholder value.
  • Such strategic alternatives could involve a sale of a portion or the entirety of the business.
  • We have received inbound interest in the Company and, given this level of interest, the Board has made the decision to review strategic alternatives.
  • There is no set timetable for the strategic review process and Horizon Global does not intend to provide updates unless or until the Board approves a specific action or otherwise determines that disclosure is appropriate or necessary.

PennantPark Floating Rate Capital Ltd. Announces Public Offering of Common Stock

Retrieved on: 
Monday, August 8, 2022 - 9:26pm

MIAMI, Aug. 08, 2022 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the Company) (NYSE: PFLT) (TASE: PFLT) today announced that it has commenced an underwritten primary offering of shares of its common stock (the Offering).

Key Points: 
  • MIAMI, Aug. 08, 2022 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the Company) (NYSE: PFLT) (TASE: PFLT) today announced that it has commenced an underwritten primary offering of shares of its common stock (the Offering).
  • About PennantPark Floating Rate Capital Ltd.
    PennantPark Floating Rate Capital Ltd. is a business development company which primarily invests in U.S. middle-market companies in the form of floating rate senior secured loans, including first lien secured debt, second lien secured debt and subordinated debt.
  • PennantPark Floating Rate Capital Ltd. is managed by PennantPark Investment Advisers, LLC.
  • PennantPark Floating Rate Capital Ltd. undertakes no duty to update any forward-looking statement made herein.

Sovos Brands Announces Launch of Secondary Public Offering

Retrieved on: 
Monday, August 8, 2022 - 9:09pm

LOUISVILLE, Colo., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Sovos Brands, Inc. (Sovos Brands) (Nasdaq: SOVO), one of the fastest growing food companies of scale in the United States, today announced that certain stockholders of Sovos Brands (the Selling Stockholders) intend to offer 8,500,000 shares of Sovos Brands common stock, par value $0.001 per share (the Common Stock), in an underwritten secondary public offering.

Key Points: 
  • LOUISVILLE, Colo., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Sovos Brands, Inc. (Sovos Brands) (Nasdaq: SOVO), one of the fastest growing food companies of scale in the United States, today announced that certain stockholders of Sovos Brands (the Selling Stockholders) intend to offer 8,500,000 shares of Sovos Brands common stock, par value $0.001 per share (the Common Stock), in an underwritten secondary public offering.
  • Sovos Brands, Inc. is a consumer-packaged food company focused on acquiring and building disruptive growth brands that bring todays consumers great tasting food that fits the way they live.
  • SOVOS, RAO'S, RAO'S HOMEMADE, NOOSA, BIRCH BENDERS and MICHAEL ANGELO'S are trademarks of Sovos Brands and its subsidiaries.
  • Certain information contained in this press release has been obtained from sources outside of Sovos Brands.

Vietnam Rice Industry Report 2022-2031: Development Environment, Supply and Demand, Import and Export, Market Competition, Major Companies, Outlook - ResearchAndMarkets.com

Retrieved on: 
Monday, August 8, 2022 - 1:10pm

In terms of price, the average price of Vietnam's rice exports in 2021 dropped 3.83 percent year on year to $477 per ton.

Key Points: 
  • In terms of price, the average price of Vietnam's rice exports in 2021 dropped 3.83 percent year on year to $477 per ton.
  • Imports volumes and values of Vietnam's Rice, 2016-2021
    Forecast on Imports volumes and values of Vietnam's Rice, 2022-2031
    What are the key drivers, challenges, and opportunities for the rice industry in Vietnam during 2022-2031?
  • What are the strategies adopted by the key players in the market to increase their market share in the industry?
  • Which segment of Vietnam's rice market is expected to dominate the market in 2031?

Seacoast Announces Agreement to Acquire Professional Holding Corp.

Retrieved on: 
Monday, August 8, 2022 - 1:05pm

Seacoast Banking Corporation of Florida (Seacoast) (NASDAQ: SBCF), the holding company for Seacoast National Bank (Seacoast Bank), and Professional Holding Corp. (Professional) (NASDAQ: PFHD), parent company of Professional Bank, announced today that they have signed a definitive agreement under which Seacoast will acquire Professional.

Key Points: 
  • Seacoast Banking Corporation of Florida (Seacoast) (NASDAQ: SBCF), the holding company for Seacoast National Bank (Seacoast Bank), and Professional Holding Corp. (Professional) (NASDAQ: PFHD), parent company of Professional Bank, announced today that they have signed a definitive agreement under which Seacoast will acquire Professional.
  • Professional Bank and Seacoast have closely aligned cultures with shared business values that are focused on maintaining disciplined underwriting and a strict credit culture, said Abel Iglesias, President and CEO of Professional Holding Corp.
  • Under the terms of the acquisition agreement, Professional shareholders are to receive 0.8909 shares of Seacoast common stock for each share of Professional common stock.
  • Following completion of the transaction and system integrations, Professional Bank will operate as Seacoast Bank.

Seacoast Announces Agreement to Acquire Professional Holding Corp.

Retrieved on: 
Monday, August 8, 2022 - 12:59pm

STUART, Fla., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Seacoast Banking Corporation of Florida (Seacoast) (NASDAQ: SBCF), the holding company for Seacoast National Bank (Seacoast Bank), and Professional Holding Corp. (Professional) (NASDAQ: PFHD), parent company of Professional Bank, announced today that they have signed a definitive agreement under which Seacoast will acquire Professional.

Key Points: 
  • STUART, Fla., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Seacoast Banking Corporation of Florida (Seacoast) (NASDAQ: SBCF), the holding company for Seacoast National Bank (Seacoast Bank), and Professional Holding Corp. (Professional) (NASDAQ: PFHD), parent company of Professional Bank, announced today that they have signed a definitive agreement under which Seacoast will acquire Professional.
  • Professional Bank and Seacoast have closely aligned cultures with shared business values that are focused on maintaining disciplined underwriting and a strict credit culture, said Abel Iglesias, President and CEO of Professional Holding Corp.
  • We are thrilled to join the Seacoast franchise and together become a major presence as one of South Floridas largest community banks.
  • Under the terms of the acquisition agreement, Professional shareholders are to receive 0.8909 shares of Seacoast common stock for each share of Professional common stock.

Nordson Corporation Announces Agreement to Acquire CyberOptics Corporation, Expanding Its Semiconductor Test and Inspection Capabilities

Retrieved on: 
Monday, August 8, 2022 - 12:30pm

Nordson Corporation (Nasdaq: NDSN) has signed a definitive agreement for the acquisition of CyberOptics Corporation (Nasdaq: CYBE), a leading global developer and manufacturer of high-precision 3D optical sensing technology solutions.

Key Points: 
  • Nordson Corporation (Nasdaq: NDSN) has signed a definitive agreement for the acquisition of CyberOptics Corporation (Nasdaq: CYBE), a leading global developer and manufacturer of high-precision 3D optical sensing technology solutions.
  • The acquisition enhances Nordsons test and inspection platform, providing differentiated technology that expands Nordsons product offering in the semiconductor and electronics industries.
  • The companys leading-edge 3D optical sensing technology and market leading wireless measurement sensors will expand Nordsons current test and inspection capabilities, allowing us to offer new differentiated solutions to our semiconductor and electronics customers.
  • CyberOptics sensors are used for inspection and metrology in the semiconductor and surface mount technology (SMT) markets to improve yields and productivity.